MAM
ZNTL icon

Marquette Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Marquette Asset Management’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Buy
+28,973
New +$116K 0.02% 120

Other funds holding ZNTL

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Marquette Asset Management's ZNTL Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q2 2026: 28,973 shares worth $141K. The stake represents 0.02% of the portfolio and ranks #120 among its holdings.

2 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Marquette Asset Management held 28,973 shares of Zentalis Pharmaceuticals worth $141K as of Q2 2026.
  • Zentalis Pharmaceuticals was a new Marquette Asset Management position in Q2 2026.
  • Zentalis Pharmaceuticals made up 0.02% of Marquette Asset Management's portfolio in Q2 2026, its #120 holding.
  • 2 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.